The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Hospital and Societal Costs of Antimicrobial‐Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship
Open accessAbstract
BACKGROUND: Organisms resistant to antimicrobials continue to emerge and spread. This study was performed to measure the medical and societal cost attributable to antimicrobial-resistant infection (ARI). METHODS: A sample of high-risk hospitalized adult patients was selected. Measurements included ARI, total cost, duration of stay, comorbidities, acute pathophysiology, Acute Physiology and Chronic Health Evaluation III score, intensive care unit stay, surgery, health care-acquired infection, and mortality. Hospital services used and outcomes were abstracted from electronic and written medical records. Medical costs were measured from the hospital perspective. A sensitivity analysis including 3 study designs was conducted. Regression was used to adjust for potential confounding in the random sample and in the sample expanded with additional patients with ARI. Propensity scores were used to select matched control subjects for each patient with ARI for a comparison of mean cost for patients with and without ARI. RESULTS: In a sample of 1391 patients, 188 (13.5%) had ARI. The medical costs attributable to ARI ranged from $18,588 to $29,069 per patient in the sensitivity analysis. Excess duration of hospital stay was 6.4-12.7 days, and attributable mortality was 6.5%. The societal costs were $10.7-$15.0 million. Using the lowest estimates from the sensitivity analysis resulted in a total cost of $13.35 million in 2008 dollars in this patient cohort. CONCLUSIONS: The attributable medical and societal costs of ARI are considerable. Data from this analysis could form the basis for a more comprehensive evaluation of the cost of resistance and the potential economic benefits of prevention programs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU
Pronovost, P., Needham, D., Berenholtz, S., Sinopoli, D., Chu, H., Cosgrove, S., Sexton, B., Hyzy, R., Welsh, R., Roth, G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061115 · Cited by 4,387
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726 · cited 1×
“The emergence of antimicrobial-resistant organisms is accelerating, and novel drug development is not keeping pace [1–9].”
BackgroundThe APACHE III Prognostic System
Teres, D., & Lemeshow, S. (1992) · Chest · doi:10.1378/chest.102.6.1919b · Cited by 2,880
Horan, T. C., Gaynes, R. P., Martone, W. J., Jarvis, W. R., & Grace Emori, T. (1992) · American Journal of Infection Control · doi:10.1016/s0196-6553(05)80201-9 · Cited by 2,609
A critical appraisal of propensity‐score matching in the medical literature between 1996 and 2003
Austin, P. C. (2008) · Statistics in Medicine · doi:10.1002/sim.3150 · Cited by 1,249
Engemann, J. J., Carmeli, Y., Cosgrove, S. E., Fowler, V. G., Bronstein, M. Z., Trivette, S. L., Briggs, J. P., Sexton, D. J., & Kaye, K. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367653 · Cited by 934
Trends in antimicrobial drug development: Implications for the future
Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/420937 · Cited by 867
Goldmann, D. A. (1996) · JAMA · doi:10.1001/jama.1996.03530270074035 · Cited by 753
Kurth, T., Walker, A. M., Glynn, R. J., Chan, K. A., Gaziano, J. M., Berger, K., & Robins, J. M. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj047 · Cited by 730
Ambulatory Medical Care Utilization Estimates for 2006: (587152010-001)
Schappert, S. M., & Rechtsteiner, E. A. (2008) · PsycEXTRA Dataset · doi:10.1037/e587152010-001 · Cited by 699
The Impact of Antimicrobial Resistance on Health and Economic Outcomes
Eliopoulos, G. M., Cosgrove, S. E., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/375081 · Cited by 637
Prevention effectiveness : a guide to decision analysis and economic evaluation
Haddix, A. C. (1996) · Cited by 576
The Economic Impact of Staphylococcus aureus Infection in New York City Hospitals
Rubin, R. J., Harrington, C. A., Poon, A., Dietrich, K., Greene, J. A., & Moiduddin, A. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0501.990102 · Cited by 445
The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions
Lipsitch, M., Bergstrom, C. T., & Levin, B. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1938 · Cited by 424
Universal Surveillance for Methicillin-Resistant Staphylococcus aureus in 3 Affiliated Hospitals
Robicsek, A., Beaumont, J. L., Paule, S. M., Hacek, D. M., Thomson, R. B., Kaul, K. L., King, P., & Peterson, L. R. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-6-200803180-00003 · Cited by 417
The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus
Appelbaum, P. C. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01344.x · Cited by 376
Roberts, R. R. (1997) · JAMA · doi:10.1001/jama.278.20.1670 · Cited by 352
Self-citationDistribution of Variable vs Fixed Costs of Hospital Care
Roberts, R. R. (1999) · JAMA · doi:10.1001/jama.281.7.644 · Cited by 300
Self-citationCosgrove, S. E., Kaye, K. S., Eliopoulous, G. M., & Carmeli, Y. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.2.185 · Cited by 299
Controlling Antimicrobial Resistance in Hospitals: Infection Control and Use of Antibiotics
Weinstein, R. A. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010206 · Cited by 275
Self-citationZimmerman, J. E., Kramer, A. A., McNair, D., Malila, F. M., & Shaffer, V. L. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000240233.01711.d9 · Cited by 272
McKibben, L., Horan, T. C., Tokars, J. I., Fowler, G., Cardo, D. M., Pearson, M. L., Brennan, P. J., & Healthcare Infection Control Practices Advisory Committee (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502585 · Cited by 255
Wait-and-See Prescription for the Treatment of Acute Otitis Media: A Randomized Controlled Trial
Spiro, D. M., Tay, K.-Y., Arnold, D. H., Dziura, J. D., Baker, M. D., & Shapiro, E. D. (2006) · JAMA · doi:10.1001/jama.296.10.1235 · Cited by 253
Health and Economic Outcomes of Vancomycin-Resistant Enterococci
Carmeli, Y., Eliopoulos, G., Mozaffari, E., & Samore, M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.19.2223 · Cited by 249
Clinical Decision Support and Appropriateness of Antimicrobial Prescribing: A Randomized Trial
Samore, M. H., Bateman, K., Alder, S. C., Hannah, E., Donnelly, S., Stoddard, G. J., Haddadin, B., Rubin, M. A., Williamson, J., Stults, B., et al. (2005) · JAMA · doi:10.1001/jama.294.18.2305 · Cited by 210
Changes in Antibiotic Prescribing for Children After a Community-wide Campaign
Perz, J. F. (2002) · JAMA · doi:10.1001/jama.287.23.3103 · Cited by 184
Development of a Clinical Data Warehouse for Hospital Infection Control
Wisniewski, M. F., Kieszkowski, P., Zagorski, B. M., Trick, W. E., Sommers, M., & Weinstein, R. A. (2003) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m1299 · Cited by 160
Self-citationRaising Standards While Watching the Bottom Line Making a Business Case for Infection Control
Perencevich, E. N., Stone, P. W., Wright, S. B., Carmeli, Y., Fisman, D. N., & Cosgrove, S. E. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/521852 · Cited by 138
Hill, J. (2008) · Statistics in Medicine · doi:10.1002/sim.3245 · Cited by 131
Song, X., Srinivasan, A., Plaut, D., & Perl, T. M. (2003) · Infection Control and Hospital Epidemiology · doi:10.1086/502196 · Cited by 127
The Use of Economic Modeling to Determine the Hospital Costs Associated with Nosocomial Infections
Roberts, R. R., Scott, R. D., Cordell, R. L., Solomon, S. L., Steele, L., Kampe, L. M., Trick, W. E., & Weinstein, R. A. (2003) · Clinical Infectious Diseases · doi:10.1086/375061 · Cited by 113
Self-citationCan Disease Management Target Patients Most Likely to Generate High Costs? The Impact of Comorbidity
Charlson, M. E., Charlson, R. E., Briggs, W. M., & Hollenberg, J. P. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0130-7 · Cited by 98
Rifampicin Resistance in Tuberculosis Outbreak, London, England
Jenkins, C., Claxton, A. P., Shorten, R. J., McHugh, T. D., & Gillespie, S. H. (2005) · Emerging infectious diseases · doi:10.3201/eid1106.050118 · Cited by 97
Howard, D. H., Cordell, R. L., McGowan, J. E., Packard, R. M., Scott, R. D., Solomon, S. L., & the Workshop Group (2001) · Clinical Infectious Diseases · doi:10.1086/323758 · Cited by 80
Self-citationSintchenko, V., Coiera, E. W., Iredell, J. R., & Gilbert, G. L. (2003) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m1166 · Cited by 77
Improving Antibiotic Selection
Steinman, M. A., Ranji, S. R., Shojania, K. G., & Gonzales, R. (2006) · Medical Care · doi:10.1097/01.mlr.0000215846.25591.22 · Cited by 76
Antimicrobial Use Control Measures to Prevent and Control Antimicrobial Resistance in US Hospitals
Zillich, A. J., Sutherland, J. M., Wilson, S. J., et al. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/507963 · Cited by 55
Aiello, A. E., King, N. B., & Foxman, B. (2006) · American Journal of Public Health · doi:10.2105/ajph.2005.077214 · Cited by 30
Appropriate Use of Antimicrobial Drugs: A Better Prescription Is Needed
Weber, J. T. (2005) · JAMA · doi:10.1001/jama.294.18.2354 · Cited by 19
Iannini, P. B. (2003) · Southern Medical Journal · doi:10.1097/01.smj.0000054422.04163.86 · Cited by 7
Cited by
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Ben, Y., Fu, C., Hu, M., Liu, L., Wong, M. H., & Zheng, C. (2019) · Environmental Research · doi:10.1016/j.envres.2018.11.040 · Cited by 1,268
Tackling antibiotic resistance
Bush, K., Courvalin, P., Dantas, G., Davies, J., Eisenstein, B., Huovinen, P., Jacoby, G. A., Kishony, R., Kreiswirth, B. N., Kutter, E., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2693 · Cited by 1,062
Self-citationAntimicrobial resistance: A global emerging threat to public health systems
Ferri, M., Ranucci, E., Romagnoli, P., & Giaccone, V. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1077192 · Cited by 1,049
Li, B., & Webster, T. J. (2018) · Journal of Orthopaedic Research · doi:10.1002/jor.23656 · Cited by 907
Metadata
- Authors
- Roberts, R. R., Hota, B., Ahmad, I., Scott II, R. D., Foster, S. D., Abbasi, F., Schabowski, S., Kampe, L. M., Ciavarella, G. G., Supino, M., Naples, J., Cordell, R., Levy, S. B., & Weinstein, R. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-10-15
- Volume
- 49
- Issue
- 8
- Pages
- 1175-1184
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2139806506
- Cited by
- 705
- References
- 42
- FWCI
- 43.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.